New Therapy for Ovarian Cancer

Publisher Website
Google Scholar
Abstract
Cancer of the ovarian epithelium is the fourth most common cause of death from cancer in women and the leading cause of death from gynecologic cancer. At the time of diagnosis, the majority of women with the disease have involvement of one or both ovaries, with peritoneal implants outside the pelvis or positive retroperitoneal–inguinal nodes (stage III, according to the classification of the International Federation of Gynaecology and Obstetrics), or they have distant metastases (stage IV).1 Surgery and chemotherapy are the cornerstones of therapy for advanced ovarian cancer. Before chemotherapy is initiated, a maximal effort should be made to remove . . .